Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Amit Patel

Orthopaedic Surgery York, PA Medical Doctor

NPI 1376604025 CMS profile 334930

1855 Powder Mill Rd, York, PA 17402

Open in the dashboard

General payments

$311,621

365 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amit Patel of York, PA is reported in the CMS Open Payments database as having received $311,621 across 365 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $62,026 72
2024 General $61,159 39
2023 General $49,532 44
2022 General $51,093 51
2021 General $49,103 61
2020 General $20,494 30
2019 General $18,213 68

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amit Patel
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Amit Patel were reported at $62,026. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Amit Patel Orthopaedic Surgery median Middle half National median
2019 $18,213 $644 $140–$2,844 $163
2020 $20,494 $312 $75–$1,860 $114
2021 $49,103 $520 $117–$2,495 $132
2022 $51,093 $598 $128–$2,731 $149
2023 $49,532 $461 $128–$2,264 $160
2024 $61,159 $497 $134–$2,475 $164
2025 $62,026 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $118,188 114 payments
  2. Alphatec Spine, Inc $94,300 55 payments
  3. SI-BONE, Inc. $32,087 53 payments
  4. VB Spine LLC $24,091 20 payments
  5. Globus Medical, Inc. $10,091 23 payments
  6. Highridge Medical LLC $8,384 9 payments
  7. SC Medica $5,377 2 payments
  8. NuVasive, Inc. $5,057 13 payments
  9. Zavation LLC $3,973 3 payments
  10. CoreLink, LLC $1,240 8 payments
  11. Other $8,834 65 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $259,331 91 payments
  2. Travel and Lodging $40,013 108 payments
  3. Food and Beverage $12,277 166 payments
Products named General payments · program years 2019–2025
  1. SafeOp $46,277 9 payments
  2. Other - Miscellaneous $43,691 23 payments
  3. CASCADIA INTERBODY SYSTEM $32,807 24 payments
  4. ES2 SPINAL SYSTEM $32,096 14 payments
  5. IFUSE IMPLANT $20,887 36 payments
  6. NIAGARA LATERAL ACCESS SYSTEM $20,865 9 payments
  7. CANYON RETRACTOR SYSTEMS $20,063 4 payments
  8. RAVINE LATERAL ACCESS SYSTEM $13,500 2 payments
  9. TRITANIUM $13,024 6 payments
  10. IFUSE IMPLANT SYSTEM $10,522 11 payments
  11. Other $87,318 184 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

260

Median for Orthopedic Surgery: 203

Drug cost

$1,804

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 69 $709
Methylprednisolone Generic 53 $335
Tizanidine Hcl Generic 32 $242
Mupirocin Generic 30 $202
Diclofenac Sodium Generic 15 $152
Meloxicam Generic 49 $152
Alprazolam Generic 12 $11

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$195,535

Medicare's payments for the services billed

Medicare patients

404

Average age 74

Services billed

1,192

237 women, 167 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 32%
Depression 32%
Ischemic heart disease 28%
Chronic kidney disease 26%
Osteoporosis 20%
Cancer 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

365 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record